Coverage Decisions May Drive Potential Health Care System Inefficiency
New research from Tufts Medical Center and the National Pharmaceutical Council indicates that patient access to therapies depends on factors other than cost and clinical benefit.
NPC in Specialty Pharmacy Times: How Do We Pay for Medical Innovation?
In the March issue of Specialty Pharmacy Times, NPC President Dan Leonard says it’s time to think differently about how we pay for health care and assess value and benefits.
National Pharmaceutical Council Welcomes Four Biopharmaceutical Companies as Members
The National Pharmaceutical Council welcomed four companies, AstraZeneca, Gilead Sciences, Horizon Pharma and Spark Therapeutics, as the newest members of the health care research organization.
